Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$230M |
| 2 |
Johnson & Johnson
JNJ
|
+$205M |
| 3 |
Bank of America
BAC
|
+$163M |
| 4 |
Costco
COST
|
+$162M |
| 5 |
GSK
GSK
|
+$131M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
IBM
IBM
|
+$396M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$219M |
| 3 |
GE Aerospace
GE
|
+$156M |
| 4 |
Walt Disney
DIS
|
+$154M |
| 5 |
Amazon
AMZN
|
+$138M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.36% |
| 2 | Healthcare | 13.06% |
| 3 | Consumer Discretionary | 12.03% |
| 4 | Consumer Staples | 11.17% |
| 5 | Industrials | 10.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2626
Future FinTech Group
FTFT
$1.74M
| $194K | ﹤0.01% |
17
-1
| -6% | -$12.1K |
|
|
ELGX
2627
DELISTED
Endologix Inc
ELGX
| $194K | ﹤0.01% |
+1,110
| New | +$191K |
|
|
SOCB
2628
DELISTED
SOUTHCOAST FINANCIAL CORP
SOCB
| $193K | ﹤0.01% |
33,255
+4,200
| +14% | +$24.4K |
|
2629
Electro-Sensors
ELSE
$27.3M
| $192K | ﹤0.01% |
47,800
+3,000
| +7% | +$12K |
|
2630
Gray Media Inc
GTN.A
$699M
| $192K | ﹤0.01% |
14,900
+1,400
| +10% | +$13.1K |
|
|
THMO
2631
DELISTED
ThermoGenesis Holdings, Inc. Common Stock
THMO
| $191K | ﹤0.01% |
21
-4
| -16% | -$31.8K |
|
|
GDEN
2632
DELISTED
Golden Entertainment
GDEN
| $190K | ﹤0.01% |
24,000
-1,700
| -7% | -$13.8K |
|
2633
IT Tech Packaging
ITP
$2.86M
| $190K | ﹤0.01% |
7,130
+1,500
| +27% | +$34.6K |
|
|
GIGA
2634
DELISTED
Giga-Tronics Inc
GIGA
| $189K | ﹤0.01% |
205,000
-600
| -0.3% | -$615 |
|
2635
Imunon
IMNN
$6.47M
| $188K | ﹤0.01% |
+18
| New | +$216K |
|
2636
Silicon Motion
SIMO
$7.11B
| $188K | ﹤0.01% |
13,262
-151,417
| -92% | -$2.07M |
|
2637
Vista Gold
VGZ
$250M
| $186K | ﹤0.01% |
490,500
+27,000
| +6% | +$11.2K |
|
|
ATL
2638
DELISTED
ATLATSA RES CORP RESOURCES CORP (F)
ATL
| $186K | ﹤0.01% |
323,700
+120,800
| +60% | +$55.3K |
|
|
GAI
2639
DELISTED
GLOBAL-TECH ADVANCED INNOVATIONS INC
GAI
| $186K | ﹤0.01% |
29,400
-3,100
| -10% | -$21.1K |
|
|
IRC
2640
DELISTED
INLAND REAL ESTATE CORP
IRC
| $186K | ﹤0.01% |
17,700
-212,000
| -92% | -$2.23M |
|
|
DX
2641
Dynex Capital
DX
$3.18B
| $184K | ﹤0.01% |
+7,680
| New | +$193K |
|
|
SURG
2642
DELISTED
SYNERGETICS USA, INC.
SURG
| $184K | ﹤0.01% |
50,701
+38,001
| +299% | +$155K |
|
|
WSCI
2643
DELISTED
WSI Industries Inc
WSCI
| $183K | ﹤0.01% |
30,100
-900
| -3% | -$5.46K |
|
|
OCRX
2644
DELISTED
Ocera Therapeutics, Inc.
OCRX
| $181K | ﹤0.01% |
+13,949
| New | +$130K |
|
2645
Origin Agritech
SEED
$11.9M
| $180K | ﹤0.01% |
14,180
-1,440
| -9% | -$23.4K |
|
|
MICR
2646
DELISTED
Micron Solutions, Inc.
MICR
| $180K | ﹤0.01% |
56,900
+800
| +1% | +$2.71K |
|
|
CTHR
2647
DELISTED
Charles & Colvard Ltd
CTHR
| $178K | ﹤0.01% |
3,530
-19,000
| -84% | -$1.07M |
|
|
FUBC
2648
DELISTED
1st United Bancorp (Florida)
FUBC
| $178K | ﹤0.01% |
23,400
+11,400
| +95% | +$87.8K |
|
|
INVT
2649
DELISTED
Inventergy Global, Inc.
INVT
| $177K | ﹤0.01% |
3,647
-50
| -1% | -$1.27K |
|
2650
WidePoint Corp
WYY
$97.4M
| $173K | ﹤0.01% |
10,570
+6,410
| +154% | +$67.3K |
|
Similar funds
Renaissance Technologies's Q4 2013 Portfolio in Review
As of Q4 2013, Renaissance Technologies held 3,281 positions worth $41.8B, up 1.3% from $41.2B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Renaissance Technologies withdrew a net $2.31B in Q4 2013, closing 464 positions and reducing 983 holdings. Its most notable exit was GE Aerospace, an estimated $156M position sold in full.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Renaissance Technologies opened a new position in Pfizer worth $230M.
- Renaissance Technologies's largest Q4 2013 buy was Pfizer: 7,904,832 shares worth $230M.
- Renaissance Technologies added most to Johnson & Johnson in Q4 2013, an estimated $205M increase.
- Renaissance Technologies's biggest Q4 2013 reduction was IBM, cutting an estimated $396M.
- Renaissance Technologies fully exited GE Aerospace in Q4 2013, selling an estimated $156M.
- Renaissance Technologies's ten largest holdings make up 11% of its $41.8B portfolio in Q4 2013.
- Renaissance Technologies opened 498 new positions and closed 464 in Q4 2013.
- Renaissance Technologies's portfolio value rose 1.3% quarter-over-quarter to $41.8B.
Based on Renaissance Technologies's 13F filing for Q4 2013, filed 14 Feb 2014.